Targeting Alzheimer's disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil

2017 ◽  
Vol 127 ◽  
pp. 671-690 ◽  
Author(s):  
Divan G. van Greunen ◽  
Werner Cordier ◽  
Margo Nell ◽  
Chris van der Westhuyzen ◽  
Vanessa Steenkamp ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cholinesterase Inhibitor ◽  
Chemical Space

Persistence with cholinesterase inhibitor therapy in a population-based cohort of patients with Alzheimer's disease

2010 ◽  
Vol 19 (7) ◽  
pp. 670-679 ◽  
Author(s):  
Joseph E. Amuah ◽  
David B. Hogan ◽  
Misha Eliasziw ◽  
Alison Supina ◽  
Patricia Beck ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cholinesterase Inhibitor ◽  
Population Based ◽  
Inhibitor Therapy

scholarly journals P3-350: Cholinesterase inhibitor (ChEI) treatment benefits in mild compared to moderate Alzheimer's disease

2012 ◽  
Vol 8 (4S_Part_16) ◽  
pp. P579-P579
Author(s):  
Sarah Wakefield ◽  
Simona Gardini ◽  
William McGeown ◽  
Giovanni Messa ◽  
Letizia Concari ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cholinesterase Inhibitor ◽  
Treatment Benefits ◽  
Chei Treatment

Orbital and Dorsolateral Frontal Perfusion Defect Associated With Behavioral Response to Cholinesterase Inhibitor Therapy in Alzheimer's Disease

2000 ◽  
Vol 12 (2) ◽  
pp. 209-218 ◽  
Author(s):  
Michael S. Mega ◽  
Ivo D. Dinov ◽  
Linda Lee ◽  
Susan M. O'Connor ◽  
Donna M. Masterman ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Cholinesterase Inhibitor ◽  
Behavioral Response ◽  
Perfusion Defect ◽  
Inhibitor Therapy
Sign in / Sign up

Export Citation Format

Share Document